Heterotope ossifikationen nach künstlichem hüftgelenksersatz

Operative Orthopadie und Traumatologie

Volumn 12, Issue 4, 2000, Pages 328-340

  Sell, Stefan ^a   Schleh, Thomas ^a   Handel, Martin ^a   Scheiderbauer, Jutta ^a   Becker, Gerd ^a   Bamberg, Michael ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Heterotopic ossification; Irradiation; NSAID; Prevention of heterotopic ossification; Total hip replacement

Indexed keywords

EID: 32744467782     PISSN: 09346694     EISSN: 14390981     Source Type: Journal    
DOI: 10.1007/PL00002264     Document Type: Review

References (102)

1. Abrahamson SO, Ahlgren SA, Dahlström JA, Ohlin P, Leif S. Ectopic bone after hip replacement. Excision and free fat transplants in four cases. Acta Orthop Scand 1984;55:589-92.
2. Ahrengart L. Periarticular heterotopic ossification after total hip arthroplasty. Risk factors and consequences. Clin Orthop 1991;263:49-58.
3. Ahrengart L, Blomgren G, Tornkvist H. Short-term ibuprofen to prevent ossification after hip arthroplasty. No effects in a prospective randomized study of 47 arthrosis cases. Acta Orthop Scand 1994;65:139-41.
4. Ahrengart L, Lindgren U. Functional significance of heterotopic bone formation after total hip arthroplasty. J Arthroplasty 1989;4:125-31.
5. Alberti W, Quack G, Krischke W, Lommatzsch A, Huyer C, Krahl H. Prevention of heterotopic ossification by radiotherapy following total hip prosthesis. Dtsch Med Wochenschr 1995;120:983-9.
6. Anthony P, Keys H, Evarts CM, Rubin P, Lush C. Prevention of heterotopic bone formation with early postoperative irradiation in high risk patients undergoing total hip arthroplasty: comparison of 10.00 Gy vs 20.00 Gy schedules. Int J Radiat Oncol Biol Phys 1987;13:365-9.
7. Arcq M. [Ectopic ossification: a complication after total hip replacement (author's translation).] Arch Orthop Unfallchir 1973;77:108-31.
8. Ayers DC, Evarts CM, Parkinson JR. The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty. J Bone Joint Surg [Am] 1986;68:1423-30.
9. Blount LH, Thomas BJ, Tran L, Selch MT, Sylvester JE, Parker RG. Postoperative irradiation for the prevention of heterotopic bone: analysis of different dose schedules and shielding considerations. Int J Radiat Oncol Biol Phys 1990;19:577-81.
10. Brady LW. Radiation-induced sarcomas of bone. Skeletal Radiol 1979;4:72-8.
11. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg [Am] 1973;55:1629-32.
12. Charnley J. The long-term results of low-friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg [Br] 1972;54:61-76.
13. Chen TH, Huang CK, Chen WM, Chiang CC, Lo WH. Heterotopic ossification after cemented or uncemented bateman bipolar hemiarthroplasty. Chung Hua I Hsueh Tsa Chili (Taipei) 1998;61: 520-3.
14. Coventry MB, Scanlon PW. The use of radiation to discourage ectopic bone. A nine-year study in surgery about the hip. J Bone Joint Surg [Am] 1981; 63:201-8.
15. DeFlitch CJ, Stryker JA. Postoperative hip irradiation in prevention of heterotopic ossification: causes of treatment failure. Radiology 1993;188:265-70.
16. DeLee J, Ferrari A, Charnley J. Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 1976;121:53-9.
17. Duck HJ, Mylod AG Jr. Heterotopic bone in hip arthroplasties. Cemented versus noncemented. Clin Orthop 1992;282:145-53.
18. Dustmann HO, Godolias G. [Experiences with cement-free implantation of the Zweymuller/Endler and Zweymuller total hip joint endoprosthesis. Indications, results, complications and modification of periarticular ossification by diphosphonate (ethylidene-1-hydroxy-1,1-diphosphonate).] Z Orthop 1988; 126:314-25.
19. Eyb R. [Clinical results following the transgluteal and anterolateral (Watson-Jones) approach to hip prosthesis implantation.] Z Orthop 1985;123:966-8.
20. Eyb R, Knahr K. The effect of prophylaxis for thrombosis on heterotopic ossification following total hip joint replacement. Arch Orthop Trauma Surg 1983; 102:114-7.
21. Fingeroth RJ, Ahmed AQ. Single dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty. Clin Orthop 1995;317:131-40.
22. Friedenstein A, Kuralesova AI. Osteogenic precursor cells of bone marrow in radiation chimeras. Transplantation 1971;12:99-108.
23. Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998;158:33-9.
24. Gebuhr P, Sletgard J, Dalsgard J, Soelberg M, Keisu K, Hanninen A, Crawford M. Heterotopic ossification after hip arthroplasty: a randomized doubleblind multicenter study of tenoxicam in 147 hips. Acta Orthop Scand 1996;67:29-32.
25. Gebuhr P, Wilbek H, Soelberg M. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty. Clin Orthop 1995;314:166-9.
26. Gierse H, Scherberich M, Fuchs S. [Does the type of prosthesis have an effect on the development of periarticular ossification?] Z Orthop Ihre Grenzgeb 1994; 132:516-20.
27. Goel A, Sharp DJ. Heterotopic bone formation after hip replacement. The influence of the type of osteoarthritis. J Bone Joint Surg [Br] 1991;73:255-7.
28. Gregoritch SJ, Chadha M, Pelligrini VD, Rubin P, Kantorowitz DA. Randomized trial comparing preoperative versus postoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement: preliminary results. Int J Radiat Oncol Biol Phys 1994;30:55-62.
29. Guillemin F, Mainard D, Rolland H, Delagoutte JP. Antivitamin K prevents heterotopic ossification after hip arthroplasty in diffuse idiopathic skeletal hyperostosis. A retrospective study in 67 patients. Acta Orthop Scand 1995;66:123-6.
30. Hamblen DL, Harris WH. Myositis ossificans as a complication of hip arthroplasty. J Bone Joint Surg [Br] 1971;53:764.abstract.
31. Hanslik L, Radloff H. [The pathological significance of paraarticular ossifications after total hip replacements (author's translation).] Arch Orthop Unfallchir 1974;80:153-64.
32. Hartwig CH, Sell S, Kusswetter W. [Periarticular ossification following cement-free and cement fixed total endoprosthesis implantation in the hip joint.] Z Orthop 1989;127:296-301.
33. Hawkey CJ. Healing and prevention of NSAID-induced peptic ulcers. Scand J Gastroenterol Suppl 1994;201:42-4.
34. Healy WL, Lo TC, DeSimone AA, Rask B, Pfeifer BA. Single-dose irradiation for the prevention of heterotopic ossification after total hip arthroplasty. A comparison of doses of five hundred and fifty and seven hundred centigray. J Bone Joint Surg [Am] 1995;77:590-5.
35. Hedley AK, Mead LP, Hendren DH. The prevention of heterotopic bone formation following total hip arthroplasty using 600 rad in a single dose. J Arthroplasty 1989;4:319-25.
36. Heyd R, Schopohl B, Kirchner J, Bottcher HD. Preoperative radiotherapy for prevention of heterotopic ossifications after hip endoprosthesis. Aktuelle Radiol 1997;7:270-3.
37. Heyd R, Strassmann G, Kirchner J, Schopohl B, Bottcher HD. Postoperative radiotherapy in the prevention of heterotopic ossification after endoprosthetic hip joint replacement. Strahlenther Onkol 1996; 172:543-52.
38. Hierton C, Blomgren G, Lindgren U. Factors associated with heterotopic bone formation in cemented total hip prostheses. Acta Orthop Scand 1983;54:698-702.
39. Hogevold HE, Grogaard B, Reikeras O. Effects of short-term treatment with corticosteroids and indomethacin on bone healing. A mechanical study of osteotomies in rats. Acta Orthop Scand 1992;63:607-11.
40. Holz U, Kraner F, Weller S. [Periarticular ossification following replacement of the hip-joint. Clinical and radiologic examination of 697 hip-joints (author's translation).] Z Orthop 1977;115:146-58.
41. Hu HP, Kuijpers W, Slooff TJ, van Horn JR, Versleyen DH. The effect of biphosphonate on induced heterotopic bone. Clin Orthop 1991;272:259-67.
42. Jacobsson SA, Djerf K, Ivarsson I, Wahlstrom O. Effect of diclofenac on fixation of hydroxyapatite-coated implants. An experimental study. J Bone Joint Surg [Br] 1994;76:831-3.
43. Jockheck M, Willms R, Volkmann R, Sell S, Weller S, Kusswetter W. Prevention of periarticular heterotopic ossification after endoprosthetic hip joint replacement by means of diclofenac. Arch Orthop Trauma Surg 1998;117:337-40.
44. Kaysinger KK, Ramp WK, Lang GJ, Gruber HE. Comparison of human osteoblasts and osteogenic cells from heterotopic bone. Clin Orthop 1997; 342:181-91.
45. Kennedy WF, Gruen TA, Chessin H, Gasparini G, Thompson W. Radiation therapy to prevent heterotopic ossification after cementless total hip arthroplasty. Clin Orthop 1991;262:185-91.
46. Kim JH, Chu FC, Woodard HQ, Melamed MR, Huvos A, Cantin J. Radiation-induced soft-tissue and bone sarcoma. Radiology 1978;129:501-8.
47. Kjaersgaard Andersen P, Nafei A, Teichert G, Kristensen O, Schmidt SA, Keller J, Lucht U. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties. Acta Orthop Scand 1993;64:639-42.
48. Kjaersgaard Andersen P, Pedersen P, Kristensen SS, Schmidt SA, Pedersen NW. Serum alkaline phosphatase as an indicator of heterotopic bone formation following total hip arthroplasty. Clin Orthop 1988; 234:102-9.
49. Kjaersgaard Andersen P, Ritter MA. Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. A preliminary report. Clin Orthop 1992;279:157-62.
50. Knahr K, Salzer M, Eyb R, Frank P, Blauensteiner W. Heterotopic ossification with total hip endoprostheses in various models of thrombosis prophylaxis. J Arthroplasty 1988;3:1-8.
51. Knelles D, Barthel T, Karrer A, Kraus U, Eulert J, Kolbl O. Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J Bone Joint Surg [Br] 1997;79:596-602.
52. Kölbl O, Flentje M, Eulert J, Barthel T, Knelles D, Kraus U. Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy. Strahlenther Onkol 1997;173: 677-82.
53. Kölbl O, Knelles D, Barthel T, Raunecker F, Flentje M, Eulert J. Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial. Int J Radiat Oncol Biol Phys 1998;42:397-401.
54. Konski A, Pellegrini V, Poulter C, DeVanny J, Rosier R, Evarts CM, Henzler M, Rubin P. Randomized trial comparing single dose versus fractionated irradiation for prevention of heterotopic bone: a preliminary report. Int J Radiat Oncol Biol Phys 1990; 18:1139-42.
55. Koorevaar CT, Hu HP, Lemmens A, van Kampen A. No effective prophylaxis of heterotopic ossification with short-term ibuprofen. Arch Orthop Trauma Surg 1999;119:183-5.
56. Kromann Andersen C, Sorensen TS, Hougaard K, Zdravkovic D, Frigaard E. Ectopic bone formation following Charnley hip arthroplasty. Acta Orthop Scand 1980;51:633-8.
57. Lazansky MG. Complications revisited. The debit side of total hip replacement. Clin Orthop 1973;95: 96-103.
58. Linclau L, Dokter G, Debois JM, Gutwirth P. Radiation therapy to prevent heterotopic ossification in cementless total hip arthroplasty. Acta Orthop Belg 1994;60:220-4.
59. Lo TC, Healy WL, Covall DJ, Dotter WE, Pfeifer BA, Torgerson WR, Wasilewski SA. Heterotopic bone formation after hip surgery: prevention with single-dose postoperative hip irradiation. Radiology 1988;168:851-4.
60. MacLennan I, Keys HM, Evarts CM, Rubin P. Usefulness of postoperative hip irradiation in the prevention of heterotopic bone formation in a high risk group of patients. Int J Radiat Oncol Biol Phys 1984;10:49-53.
61. Maloney WJ, Krushell RJ, Jasty M, Harris WH. Incidence of heterotopic ossification after total hip replacement: effect of the type of fixation of the femoral component. J Bone Joint Surg [Am] 1991;73: 191-3.
62. Martini F, Sell S, Reize P, Jany R, Kusswetter W. Perioperative side effects of preventative measures against heterotopic ossification - diclofenac versus irradiation. Akt Rheumatol 1995;20:61-5.
63. Menon PC, Griffiths WE, Hook WE, Higgins B. Trochanteric osteotomy in total hip arthroplasty: comparison of 2 techniques. J Arthroplasty 1998; 13:92-6.
64. Metzenroth H, Publig W, Knahr K, Zandl C, Kuchner G, Carda C. [Prevention of ossification after total hip endoprosthesis with indomethacin and its effect on gastric mucosa.] Ossifikationsprophylaxe nach Hüfttotalendoprothesen mit Indometacin und ihr Einfluß auf die Magenschleimhaut. Z Orthop Ihre Grenzgeb 1991;129:178-82.
65. Moore KD, Goss K, Anglen JO. Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: a randomised, prospective study. J Bone Joint Surg [Br] 1998; 80:259-63.
66. Morrey BF, Adams RA, Cabanela ME. Comparison of heterotopic bone after anterolateral, transtrochanteric, and posterior approaches for total hip arthroplasty. Clin Orthop 1984;188:160-7.
67. Nayak KN, Mulliken B, Rorabeck CH, Bourne RB, Woolfrey MR. Prevalence of heterotopic ossification in cemented versus noncemented total hip joint replacement in patients with osteoarthrosis: a randomized clinical trial. Can J Surg 1997;40:368-74.
68. Nollen AJ, Slooff TJ. Para-articular ossifications after total hip replacement. Acta Orthop Scand 1973; 44:230-41.
69. Nollen JG, van Douveren FQ. Ectopic ossification in hip arthroplasty. A retrospective study of predisposing factors in 637 cases. Acta Orthop Scand 1993;64:185-7.
70. Orzel JA, Rudd TG. Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl Med 1985;26:125-32.
71. Owen M. Lineage of osteogenic cells and their relationship to the stromal system. Bone Miner Res 1985; 3:1.
72. Pedersen NW, Kristensen SS, Schmidt SA, Pedersen P, Kjaersgaard Andersen P. Factors associated with heterotopic bone formation following total hip replacement. Arch Orthop Trauma Surg 1989;108:92-5.
73. Pellegrini VD Jr, Konski AA, Gastel JA, Rubin P, Evarts CM. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field. J Bone Joint Surg [Am] 1992;74:186-200.
74. Persson PE, Sodemann B, Nilsson OS. Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time. Acta Orthop Scand 1998;69:111-5.
75. Pritchett JW. Ketorolac prophylaxis against heterotopic ossification after hip replacement. Clin Orthop 1995;314:162-5.
76. Purtill JJ, Eng K, Rothman RH, Hozack WJ. Heterotopic ossification. Incidence in cemented versus cementless total hip arthroplasty. J Arthroplasty 1996; 11:58-63.
77. Puzas JE, Miller MD, Rosier RN. Pathologic bone formation. Clin Orthop 1989;245:269-81.
78. Reis HJ, Kusswetter W, Schellinger T. The suppression of heterotopic ossification after total hip arthroplasty. Int Orthop 1992;16:140-5.
79. Riegler HF, Harris CM. Heterotopic bone formation after total hip arthroplasty. Clin Orthop 1976;117: 209-16.
80. Risto O, Wahlstrom O, Abdiu A. The effect of low dose diclofenac sodium administered locally on heterotopic bone formation in rats. Int Orthop 1995;19: 392-5.
81. Ritter MA, Gioe TJ. The effect of indomethacin on para-articular ectopic ossification following total hip arthroplasty. Clin Orthop 1982;167:113-7.
82. Ritter MA, Vaughan RB. Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results. J Bone Joint Surg [Am] 1977;59:345-51.
83. Rosendahl S, Christoffersen JK, Norgaard M. Paraarticular ossification following hip replacement. 70 arthroplasties ad modum Moore using McFarland's approach. Acta Orthop Scand 1977;48:400-4.
84. Sauer R, Seegenschmiedt MH, Goldmann A, Beck H, Andreas P. Prevention of periarticular ossification following endoprosthetic hip replacement using postoperative irradiation. Strahlenther Onkol 1992;168: 89-99.
85. Schmidt SA, Kjaersgaard Andersen P, Pedersen NW, Kristensen SS, Pedersen P, Nielsen JB. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial. J Bone Joint Surg [Am] 1988;70:834-8.
86. Seegenschmiedt MH, Goldmann AR, Martus P, Wolfel R, Hohmann D, Sauer R. Prophylactic radiation therapy for prevention of heterotopic ossification after hip arthroplasty: results in 141 high-risk hips. Radiology 1993;188:257-64.
87. Seegenschmiedt MH, Keilholz L, Martus P, Goldmann A, Wolfel R, Henning F, Sauer R. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy. Int J Radiat Oncol Biol Phys 1997;39:161-71.
88. Sell S, Jany R, Esenwein S, et al. [Suppression of heterotopic ossification: single-dose versus fractionated irradiation - animal study.] Z Orthop Ihre Grenzgeb 1995;133:514-9.
89. Sell S, Schleh T. C-reactive protein as an early indicator of the formation of heterotopic ossifications after total hip replacement. Arch Orthop Trauma Surg 1999;119:205-7.
90. Sell S, Schleh T. Does the application duration of diclofenac impact on clinical outcome in the prophylaxis of heterotopic ossifications? Akt Rheumatol 2001:submitted.
91. Sell S, Willms R, Jany R. The suppression of heterotopic ossifications: radiation versus NSAID therapy - a prospective study. J Arthroplasty 1998;13: 854-9.
92. Simon LS. Actions and toxicity of nonsteroidal anti-inflammatory drugs. Curr Opin Rheumatol 1996;8: 169-75.
93. Sodemann B, Persson PE, Nilsson OS. Periarticular heterotopic ossification after total hip arthroplasty for primary coxarthrosis. Clin Orthop 1988;237: 150-7.
94. Stillwell WT. Heterotopic ossification in total hip arthroplasty. In: Stillwell WT, ed. The art of total hip arthroplasty. New York: Grune & Stratton, 1987.
95. Streffer C. The effects of low radiation doses: carcinogenesis. Strahlenther Onkol 1994;170:681-8.
96. Thomas BJ, Amstutz HC. Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty. J Bone Joint Surg [Am] 1985;67:400-3.
97. Urist MR, Dovel TA, Hay PA, Strates BS. Inductive substrate for bone formation. Clin Orthop 1968;59:59-96.
98. Van Leeuwen WM, Deckers P, de Lange WJ. Preoperative irradiation for prophylaxis of ectopic ossification after hip arthroplasty. A randomized study in 62 hips. Acta Orthop Scand 1998;69:116-8.
99. Vastel L, Kerboull L, Anract P, Kerboull M. Heterotopic ossification after total hip arthroplasty: risk factors and prevention. Rev Rhum Engl Ed 1998; 65:238-44.
100. Wahlstrom O, Risto O, Djerf K, Hammerby S. Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties. Acta Orthop Scand 1991;62:419-21.
101. Wurnig C, Auersperg V, Boehler N. Short term prophylaxis against heterotopic bone after cementless hip replacement. Clin Orthop 1997;334:175-83.
102. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, van Reusling CJ, Swannell AJ, Hawbey CJ. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998; 338:719-26.